Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) EPS (Basic) : $-0.07 (TTM As of Apr. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics EPS (Basic)?

Advanced Proteome Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Apr. 2023 was $-0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2023 was $-0.07.

Advanced Proteome Therapeutics's EPS (Diluted) for the three months ended in Apr. 2023 was $-0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2023 was $-0.07.

Advanced Proteome Therapeutics's EPS without NRI for the three months ended in Apr. 2023 was $-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2023 was -0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Advanced Proteome Therapeutics EPS (Basic) Historical Data

The historical data trend for Advanced Proteome Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics EPS (Basic) Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

EPS (Basic)

Get a 7-Day Free Trial

-0.05

-0.02

-0.06

0.01

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-0.01	-0.04

Advanced Proteome Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Advanced Proteome Therapeutics's Basic EPS for the fiscal year that ended in Jul. 2022 is calculated as

Basic EPS (A: Jul. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.76	-	0)	/	39.088
	=	0.02

Advanced Proteome Therapeutics's Basic EPS for the quarter that ended in Apr. 2023 is calculated as

Basic EPS (Q: Apr. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.478	-	0)	/	40.711
	=	-0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07

Advanced Proteome Therapeutics (OTCPK:APTCF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Advanced Proteome Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

0E81:Germany APC.H:Canada

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018